Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 2,680.00
-15.00 (-0.56%)
At close: Jun 12, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 252.07 billion as of June 12, 2026. Its market cap has increased by 124.28% in one year.
Market Cap
252.07B
Enterprise Value
228.86B
Revenue
3.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,680.00
Market Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 252.07B, an increase of 94.90%. That is a compound annual growth rate of 6.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 252.07B | 15.52% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 359.17B |
| HansBiomed | 343.70B |
| Genome & Company | 259.75B |
| Kanaph Therapeutics | 249.42B |
| curacle co.,ltd. | 243.72B |
| NIBEC | 208.03B |
| ViGenCell | 201.51B |
| Y-Biologics | 198.83B |